Search results
Found 7347 matches for
Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.
EPSRC Centre for Doctoral Training in Healthcare Data Science
The EPSRC Centre for Doctoral Training in Healthcare Data Science (HDS CDT) is a four-year doctoral training programme offering integrated training and opportunities for study in computational statistics, machine learning, data engineering and infectious disease analytics within the context of ethically-responsible health research. Based at the Oxford Big Data Institute, the HDS CDT will recruit five cohorts from 2024 – 2028.
Inflammatory and Musculoskeletal Disease
The Kennedy Trust for Rheumatology Research-funded OxKen programme will fully fund 4 medical students each year from 2021-5 to undertake DPhils in the Medical Sciences Division in the fields of musculoskeletal disease, inflammation and immunology.
Computational Discovery
The DPhil in Computational Discovery is a multidisciplinary programme spanning projects in Advanced Molecular Simulations, Machine Learning and Quantum Computing to develop new tools and methodologies for life sciences discovery.
DPhil in Cancer Science
The DPhil in Cancer Science programme is unique and distinctive in offering integrated training across the following themes: Immunity, Infection & Inflammation; DNA Damage Response & Radiation Biology; Cancer Genetics & Epigenetics; and Cancer Big Data. It builds on Oxford’s outstanding research record in these areas, spanning both the University and Hospital Trust.